Investigational Site Number : 2030004
Brno 65691
3 studies enrolling now · 5 studies all time
What they study most
Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Heart Failure, Plasma Cell Myeloma, Polyneuropathy, Inflammatory Demyelinating, Chronic, Type 2 Diabetes Mellitus
Studies at this site
- A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Recruiting now
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work — Recruiting now
- Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP — Enrolling by invitation
- Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
- Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) — Stopped early